HoLEP vs TURP for BPH: Prostate Size, Bleeding, Recovery and Retreatment

HoLEP and TURP are endoscopic operations used to relieve urinary obstruction caused by BPH and benign prostate enlargement. Both remove obstructing prostate tissue through the urethra, but they use different surgical techniques: TURP progressively resects tissue into small pieces, while HoLEP enucleates larger portions of adenoma along an anatomical plane before the tissue is removed from the bladder.

01. HoLEP vs TURP for BPH: Key Clinical Differences

What is the primary difference between HoLEP and TURP for BPH?

The main difference is how obstructing prostate tissue is removed.

TURP stands for transurethral resection of the prostate. A resectoscope is passed through the prostatic urethra, and an electrosurgical loop progressively cuts obstructing tissue into smaller chips.

HoLEP stands for holmium laser enucleation of the prostate. Instead of repeatedly shaving tissue from the urethral surface, the surgeon uses holmium laser energy to develop a plane around the enlarged adenoma and separate it from the surrounding prostate.

The freed adenoma is moved into the bladder and then fragmented with a morcellator so that it can be removed through the endoscopic instrument.

Side-by-side medical illustration showing TURP removing small chips from enlarged prostate tissue with an electrosurgical loop and HoLEP separating an adenoma along the surgical plane using a laser fiber. TURP HoLEP progressive resection anatomical enucleation TISSUE REMOVED AS CHIPS ADENOMA SEPARATED ALONG PLANE
Core operative difference: TURP progressively resects tissue from inside the urinary channel. HoLEP follows the anatomical plane around the adenoma and enucleates it before morcellation.

Which features overlap and which should not be treated as the same?

HoLEP and TURP overlap in their fundamental goal: both reduce resistance at the bladder outlet by physically removing tissue surrounding the urethra.

Both are performed endoscopically through the urethra, both normally require anesthesia, both commonly involve temporary catheterization and both produce tissue that can be sent for histopathological examination.

However, they should not be described as identical operations.

FeatureHoLEPTURP
Tissue-removal principleEnucleation of adenoma along an anatomical surgical plane.Progressive electrosurgical resection from the urethral surface.
Energy sourceHolmium laser.Monopolar or bipolar electrosurgery.
Tissue extractionEnucleated tissue is typically morcellated in the bladder.Small resected chips are removed through the resectoscope.
Typical prostate-size roleBroad range, including large and very large glands.Established standard particularly around 30–80 mL.
Histopathology specimenYes.Yes.
External incisionNo.No.

The anatomical plane used during HoLEP relates to the boundary between the adenoma and surrounding prostate tissue. FBU discusses the relevant anatomy further in the prostate capsule guide.

02. How Do HoLEP and TURP Differ?

How do HoLEP and TURP differ in surgical mechanism?

TURP removes obstruction by repeatedly passing an electrosurgical loop through prostate tissue.

Each pass creates a tissue chip and gradually enlarges the cavity around the urethra.

Traditional monopolar TURP requires non-conductive irrigation fluid because electrical current travels between the resection loop and a return electrode on the patient.

Bipolar TURP confines the electrical circuit to the instrument and can use normal saline irrigation. This largely avoids the classic electrolyte disturbance known as TUR syndrome associated with absorption of electrolyte-free irrigation fluid.

HoLEP uses pulsed holmium laser energy to dissect around the adenoma. The technique more closely resembles removing the inner enlarged component as a defined mass rather than shaving it progressively from the center.

Cross-sectional comparison showing a postoperative TURP cavity after progressive tissue resection and a broader HoLEP enucleation cavity after adenoma removal. AFTER TURP AFTER HoLEP RESECTION CAVITY ENUCLEATION CAVITY obstructing tissue progressively resected adenoma removed to surgical plane
After tissue removal: both operations create a wider urinary pathway, but the shape and extent of tissue removal arise from different surgical techniques.

How does prostate size change the comparison?

Prostate volume is one of the clearest practical differences between the procedures.

Current European guidance identifies TURP as a standard surgical treatment for moderate-to-severe LUTS caused by benign prostatic obstruction in glands around 30–80 mL.

As prostate size rises, TURP takes longer because increasingly large amounts of tissue must be resected chip by chip. Longer operating time is associated with increasing perioperative risk.

HoLEP does not have the same conventional upper-volume boundary and can be used for large glands that might otherwise require another enucleation technique or simple prostatectomy.

The patient’s actual gland volume can be evaluated using ultrasound or MRI as described in How Is Prostate Volume Measured?

Clinical diagram showing TURP’s established guideline range around 30 to 80 millilitres and HoLEP extending across a broad range of prostate volumes including large glands. PROSTATE VOLUME AND PROCEDURE SELECTION 20 mL 40 mL 60 mL 80 mL 100 mL 120 mL 140 mL 160+ mL TURP · ESTABLISHED ~30–80 mL HoLEP · BROAD SIZE RANGE, INCLUDING LARGE GLANDS Volume is one treatment factor — anatomy, obstruction, bladder function, medical risk and surgeon expertise also affect procedure choice.
Clinical selection concept: TURP has its most established role around 30–80 mL, while HoLEP can be used across a much broader range of prostate sizes. Volume alone does not determine which procedure is appropriate.

03. HoLEP vs TURP for BPH: Decision Factors, Limits and Trade-Offs

How do bleeding, catheter time and hospital stay compare?

One of the most consistent perioperative advantages of HoLEP is its bleeding profile.

A 2025 meta-analysis of 13 randomized trials found that HoLEP was associated with a smaller fall in hemoglobin and fewer blood transfusions than TURP.

The same analysis found shorter catheter use and shorter hospitalization after HoLEP, while TURP generally had a shorter operating time.

Current EAU evidence similarly reports that HoLEP can provide shorter catheterization and hospitalization and a lower risk of hemorrhage in several randomized comparisons.

Perioperative factorHoLEPTURP
Blood lossGenerally lower.Generally greater than HoLEP in comparative studies.
Blood transfusionLower rate in recent randomized-trial meta-analysis.Higher relative rate in the same analysis.
Catheter durationOften shorter.Often longer in direct comparisons.
Hospital stayOften shorter.Often longer.
Operating timeCan be longer, particularly during the learning curve or in some smaller-gland comparisons.Often shorter in pooled randomized evidence.
Very large glandsEfficient enucleation can make HoLEP particularly useful.Long resection time becomes an increasing limitation.

How do urinary outcomes compare?

Both procedures substantially improve urinary symptoms, maximum urinary flow and bladder emptying when benign prostate obstruction is the main cause of the problem.

Current EAU guidance describes mid- and long-term HoLEP efficacy as broadly comparable with TURP.

A small randomized trial with approximately seven years of follow-up also found no significant long-term difference in symptom scores, quality of life, urinary flow, erectile function or continence between the two procedures.

More recent pooled long-term evidence for endoscopic enucleation techniques suggests somewhat better maximum flow and symptom scores than TURP, although the absolute differences are modest and the included studies are not all limited specifically to HoLEP.

How does retreatment compare?

Both procedures are substantially more durable than many minimally invasive treatments because they physically remove obstructing tissue.

Long-term evidence nevertheless tends to favor enucleation for reducing recurrent obstruction and repeat prostate surgery.

In one small randomized HoLEP-vs-TURP trial followed for a mean of approximately 7.6 years, none of the assessable HoLEP patients required reoperation for recurrent BPH, compared with three of 17 assessable TURP patients.

That individual study was small and had considerable loss to follow-up, so those numbers should not be treated as a universal retreatment rate.

A broader systematic review of endoscopic enucleation with four- to seven-year follow-up also found a lower pooled reoperation risk than TURP.

Current European evidence additionally reports lower overall retreatment after HoLEP than bipolar TURP in a randomized trial involving prostates above 80 mL.

How do ejaculation and erectile function compare?

Standard HoLEP and conventional TURP both frequently alter ejaculation.

After either operation, a man may still have orgasm but produce little or no semen through the penis because semen travels backward toward the bladder or the normal ejaculatory pathway has been altered.

Neither operation should therefore be presented as routinely ejaculation-preserving.

Erectile function is different. Comparative trials and guideline reviews generally show no major difference in erectile-function outcomes between HoLEP and TURP.

A man can retain good erections while experiencing a major change in ejaculation after either procedure.

04. When Does the Difference Between HoLEP and TURP Matter Clinically?

Which patient or disease factors can favor HoLEP?

HoLEP may be especially attractive when:

  • the prostate is large or very large;
  • a substantial volume of adenoma must be removed;
  • minimizing blood loss is particularly important;
  • shorter catheterization or hospitalization is desirable;
  • a durable anatomical enucleation is preferred;
  • or avoiding an open or robotic simple prostatectomy is feasible.

In very large glands, HoLEP can therefore overlap clinically with simple prostatectomy rather than only with TURP.

Which factors can favor TURP?

TURP remains a reasonable and well-established option when:

  • the prostate is within the conventional 30–80 mL range;
  • the surgeon and center have extensive TURP experience;
  • HoLEP equipment or expertise is unavailable;
  • a shorter operative time is desirable in an appropriately sized gland;
  • or the individual anatomy is well suited to conventional resection.

Modern bipolar TURP also provides an improved perioperative safety profile compared with traditional monopolar TURP and avoids classic TUR syndrome associated with electrolyte-free irrigation.

How important is surgeon experience?

Surgeon experience matters for both operations but is particularly important for HoLEP.

HoLEP requires identification of the correct enucleation plane, control of the adenoma during dissection and safe morcellation inside the bladder.

The procedure has a recognized learning curve, and outcomes improve as surgeons gain specific enucleation experience.

TURP also requires expertise, but it is a longer-established technique and is more widely available in many health systems.

When should the urinary problem be evaluated separately from procedure choice?

Choosing between HoLEP and TURP only makes sense after clinicians have reasonably established that prostate-related outlet obstruction is an important cause of the patient’s symptoms.

A large prostate or weak urinary stream alone does not establish this.

FBU explains the distinction further in prostate size, obstruction and BPH symptoms and How BPH Is Diagnosed.

Poor bladder contraction is especially important. If the detrusor muscle cannot generate adequate pressure, removing prostate obstruction may improve resistance without fully restoring bladder emptying.

Urethral stricture, neurological bladder dysfunction, infection and other conditions can also produce urinary symptoms that resemble obstruction from BPH.

What should patients ask when comparing HoLEP and TURP?

Useful questions for a surgical consultation include:

  • What is my measured prostate volume?
  • Is prostate obstruction clearly responsible for my symptoms?
  • Do I have median-lobe enlargement or unusual outlet anatomy?
  • How strong is my bladder contraction?
  • How many HoLEP or TURP procedures does this surgeon perform?
  • What are this center’s transfusion, catheter and complication rates?
  • How likely is ejaculation to change?
  • How long is catheterization usually required?
  • How often do patients at this center require retreatment?
  • Would another BPH procedure better fit my anatomy or priorities?

For the complete range of available treatments, see BPH Surgery and Minimally Invasive Procedures.

HoLEP vs TURP at a Glance

Decision factorHoLEPTURP
How tissue is removedLaser enucleation followed by morcellation.Electrosurgical loop resection into chips.
Established prostate-size roleBroad range, including large glands.Approximately 30–80 mL.
Symptom reliefStrong.Strong.
Urinary-flow improvementStrong.Strong.
Blood lossGenerally lower.Generally higher relative to HoLEP.
Transfusion riskGenerally lower.Higher in pooled randomized comparisons.
CatheterizationOften shorter.Often longer.
Hospital stayOften shorter.Often longer.
Operating timeCan be longer in some comparisons.Often shorter for conventional-size glands.
Large prostateMajor strength.Increasing gland size can make resection lengthy.
Long-term retreatmentGenerally very low; long-term evidence tends to favor enucleation.Low, but somewhat higher than enucleation in several long-term datasets.
EjaculationCommonly altered.Commonly altered.
Erectile functionNo clear major disadvantage versus TURP.No clear major advantage versus HoLEP.
Tissue pathologyYes.Yes.
Learning curveSpecialized enucleation and morcellation training.Long-established and more widely available.

Summary

  • HoLEP and TURP both physically remove benign prostate tissue to relieve bladder-outlet obstruction.
  • TURP progressively resects tissue into chips; HoLEP enucleates adenoma along an anatomical surgical plane and removes it by morcellation.
  • TURP remains a standard surgical treatment for prostates around 30–80 mL.
  • HoLEP can treat a broader range of prostate sizes, including very large glands.
  • Both procedures produce strong and durable improvements in urinary symptoms and urinary flow.
  • HoLEP generally produces less blood loss and fewer transfusions in comparative evidence.
  • Catheterization and hospital stay are often shorter after HoLEP.
  • TURP can have a shorter operating time, particularly in conventional-size prostates.
  • Long-term evidence tends to show lower reoperation rates after endoscopic enucleation than after TURP.
  • Both procedures commonly alter ejaculation.
  • Available evidence does not demonstrate a major consistent difference in erectile-function outcomes.
  • Both procedures provide tissue that can be examined histologically.
  • Poor bladder contraction can limit urinary improvement after either operation even when prostate obstruction is successfully reduced.
  • HoLEP requires specialized enucleation and morcellation expertise.
  • Neither procedure is universally best; prostate anatomy, gland size, bleeding risk, bladder function, surgical expertise and patient priorities should determine the choice.

Educational disclaimer: This article provides general medical education and does not recommend HoLEP, TURP or another BPH procedure for an individual. Appropriate surgical treatment requires evaluation of urinary symptoms, prostate anatomy, prostate volume, bladder function, medical risk and individual treatment priorities by a qualified urologist.

Explore the Prostate and BPH Pathway

For the underlying anatomy, start with Prostate Health, Prostate Anatomy and Function, the Prostatic Urethra, and Prostate Volume.

For the condition being treated, see BPH and Enlarged Prostate and How BPH Is Diagnosed.

Read the individual procedure guides for TURP for BPH and HoLEP for BPH.

For large-gland treatment context, see Simple Prostatectomy for Very Large BPH.

For the complete procedural overview, see BPH Surgery and Minimally Invasive Procedures.

Evidence Sources

  1. European Association of Urology. Management of Non-neurogenic Male LUTS — TURP and Holmium Laser Enucleation of the Prostate.
  2. HoLEP versus TURP for BPH: Meta-analysis of 13 Randomized Controlled Trials.
  3. Long-term Endoscopic Enucleation versus TURP Outcomes: Systematic Review and Meta-analysis.
  4. Gilling PJ, et al. Long-term Results of a Randomized Trial Comparing HoLEP and TURP: Results at 7 Years.
  5. American Urological Association. Surgical Management of Lower Urinary Tract Symptoms Attributed to BPH.
PreviousSimple Prostatectomy for Very Large BPH
NextUroLift vs Rezūm for BPH: Symptom Relief, Sexual Effects and Recovery

Related articles

Facebook
Twitter
LinkedIn
WhatsApp
X

Leave a Reply

Your email address will not be published. Required fields are marked *

Written by factbasedurology.

This guide was created by factbasedurology, an educational platform committed to publishing evidence-based insights on men’s sexual wellness. All content is built from credible medical literature and scientific sources, with a focus on synthesizing complex topics into accessible information. We are dedicated to helping men understand their bodies, build confidence, and take informed action

⚠️ This content is for informational purposes only and does not substitute professional medical advice. Always consult a licensed urologist for personal health concerns.

Our goal is to turn clinical knowledge into confidence — with facts you can trust.